Topic
Iran War Research
The ongoing conflict involving Iran is exerting significant upward pressure on global yields and stoking inflationary concerns, primarily through elevated energy costs. Market participants exhibit a 'jaded cynicism' regarding potential geopolitical resolutions between the U.S. and Iran, a sentiment that is keeping oil prices elevated and stalling business investment. Despite these pressures, research suggests that current market expectations for aggressive central bank rate hikes may be overstated, as they fail to account for the recessionary risks stemming from sustained high energy prices. This environment has made government bonds appear relatively inexpensive, prompting recommendations to add quality bonds with a focus on intermediate maturities as a tactical entry point. Simultaneously, the industrial sector is witnessing a price-action-driven rotation toward early-cycle groups, with names like Boeing and Alcoa gaining traction as investors adjust to shifting macro themes. However, significant risks remain as global hedge fund gross leverage reaches all-time highs and extreme positioning in certain sectors creates vulnerability for a reversal. Overall, the research direction emphasizes navigating geopolitical volatility by balancing quality bond exposure against tactical shifts in industrial and material equities.
4813 reports available
All reports
Page 201 of 201
The New Inflation Regime
TS Lombard · Apr 23, 2026
Equity Positioning and Key Levels
Goldman Sachs · Apr 13, 2026
Investment Strategy Quarterly
Raymond James · Apr 1, 2026
March and Q1 2026 Performance Review
Deutsche Bank · Apr 1, 2026
Markets and Macro
Goldman Sachs · Mar 29, 2026
Good Morning Mail
Goldman Sachs · Mar 25, 2026
Sentiment Positioning Late Cycle Tightening and Long Term Oil
Goldman Sachs International · Mar 14, 2026
Global Equities Call
Goldman Sachs · Mar 10, 2026
From Geopolitical Shocks To Structural Repricing
UBS · Mar 1, 2026
TMT Special Sales: Nvidia and Indra Beat, WPP Strategy, and Tech Conference Wrap
Goldman Sachs · Feb 26, 2026
Tactical Short: Expensive Defensives and Staples
Goldman Sachs & Co. LLC · Feb 20, 2026
When Tangible Wins
Goldman Sachs · Feb 20, 2026
Illuminating the Road Less Traveled in Biotech: Radiopharmaceuticals
William Blair · Jan 8, 2026